Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Hepatitis

  Free Subscription


Articles published in Am J Gastroenterol

Retrieve available abstracts of 73 articles:
HTML format



Single Articles


    July 2022
  1. WEINBERG EM, Dukewich M, Jakhete N, Stonesifer E, et al
    Early Liver Transplantation for Severe Alcohol-Associated Hepatitis and a History of Prior Liver Decompensation.
    Am J Gastroenterol. 2022 Jul 11. pii: 00000434-990000000-00432.
    PubMed     Abstract available


  2. GONZALEZ SA, Kamath PS
    Lung Infection in Severe Alcohol-related Hepatitis: Not to be Underestimated.
    Am J Gastroenterol. 2022;117:1044-1045.
    PubMed    


    May 2022
  3. AMPUERO J, Carmona I, Sousa F, Rosales JM, et al
    Correction to: A 2-Step Strategy Combining FIB-4 With Transient Elastography and Ultrasound Predicted Liver Cancer After HCV Cure.
    Am J Gastroenterol. 2022;117:819.
    PubMed    


  4. MORALES-ARRAEZ D, Ventura-Cots M, Altamirano J, Abraldes JG, et al
    Correction to: The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study.
    Am J Gastroenterol. 2022;117:818.
    PubMed    


    March 2022
  5. NTANDJA WANDJI LC, Ningarhari M, Lemaitre E, Khaldi M, et al
    Lung infection impacts access to treatment and short-term outcome in patients with severe alcohol-related hepatitis treated with corticosteroids.
    Am J Gastroenterol. 2022 Mar 28. pii: 00000434-990000000-00311.
    PubMed     Abstract available


  6. YUN B, Ahn SH, Yoon JH, Kim BK, et al
    Clinical indication of aspirin associated with reduced risk of liver cancer in chronic hepatitis B: A nationwide cohort study.
    Am J Gastroenterol. 2022 Mar 14. pii: 00000434-990000000-00276.
    PubMed     Abstract available


    February 2022
  7. TSENG TC, Hosaka T, Liu CJ, Suzuki F, et al
    Hepatitis B Core-related Antigen Stratifies the Risk of Liver Cancer in HBeAg-negative Patients with Indeterminate Phase.
    Am J Gastroenterol. 2022 Feb 16. pii: 00000434-990000000-00267.
    PubMed     Abstract available


  8. JENA A, Choudhury A, Singh AK
    MELD vs Maddrey Discriminant Function in Alcoholic Hepatitis: The Battle for the Best Score.
    Am J Gastroenterol. 2022 Feb 10. pii: 00000434-990000000-00248.
    PubMed    


  9. CHANG R, Chen HY, Wei JC
    Increased Cancer Risk in Autoimmune Hepatitis: A Danish Nationwide Cohort Study.
    Am J Gastroenterol. 2022 Feb 8. pii: 00000434-990000000-00243.
    PubMed    


  10. LI J, Henry L, Nguyen MH
    Chronic hepatitis B and fatty liver -weal or woe?
    Am J Gastroenterol. 2022 Feb 2. pii: 00000434-990000000-00238.
    PubMed    


    January 2022
  11. FAYED A, Hegazy MT, Biard L, Vieira M, et al
    Relapse of HCV-Cryoglobulinemic Vasculitis Following Sustained Viral Response after Interferon-free Direct-Acting Antivirals.
    Am J Gastroenterol. 2022 Jan 29. pii: 00000434-990000000-00234.
    PubMed     Abstract available


    December 2021
  12. MORALES-ARRAEZ D, Ventura-Cots M, Altamirano J, Abraldes JG, et al
    The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study.
    Am J Gastroenterol. 2021 Dec 28. pii: 00000434-990000000-00179.
    PubMed     Abstract available


  13. CACOUB P, Asselah T
    Hepatitis B Virus Infection and Extra-Hepatic Manifestations: A Systemic Disease.
    Am J Gastroenterol. 2021 Dec 16. pii: 00000434-990000000-00166.
    PubMed     Abstract available


    October 2021
  14. JENSEN MD, Jepsen P, Vilstrup H, Gronbaek L, et al
    Increased Cancer Risk in Autoimmune Hepatitis: A Danish Nationwide Cohort Study.
    Am J Gastroenterol. 2021 Oct 8. pii: 00000434-990000000-00120.
    PubMed     Abstract available


  15. LI J, Le MH, Barakat MT, Cheung RC, et al
    The Changing Epidemiology of Liver Disease Among US Children and Adolescents From 1999 to 2016.
    Am J Gastroenterol. 2021;116:2068-2078.
    PubMed     Abstract available


    September 2021
  16. LEE HW, Park SY, Lee YR, Lee H, et al
    Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL.
    Am J Gastroenterol. 2021 Sep 10. pii: 00000434-990000000-00096.
    PubMed     Abstract available


  17. AMPUERO J, Carmona I, Sousa F, Rosales JM, et al
    A 2-Step Strategy Combining FIB-4 With Transient Elastography and Ultrasound Predicted Liver Cancer After HCV Cure.
    Am J Gastroenterol. 2021 Sep 9. pii: 00000434-900000000-98663.
    PubMed     Abstract available


  18. CHUANG WL, Hu TH, Buggisch P, Moreno C, et al
    Ledipasvir/Sofosbuvir for 8, 12, or 24 Weeks in Hepatitis C Patients Undergoing Dialysis for End-Stage Renal Disease.
    Am J Gastroenterol. 2021;116:1924-1928.
    PubMed     Abstract available


  19. ZAMOR PJ, Brown A, Dylla DE, Dillon JF, et al
    High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal Adherence.
    Am J Gastroenterol. 2021;116:1896-1904.
    PubMed     Abstract available


    August 2021
  20. KONSTANTELOS N, Shakeri A, McCormack D, Feld JJ, et al
    Impact of COVID-19 on Prescribing Trends of Direct-Acting Antivirals for the Treatment of Hepatitis C in Ontario, Canada.
    Am J Gastroenterol. 2021;116:1738-1740.
    PubMed     Abstract available


    June 2021
  21. SCHAEFER EAK
    A Deep Ravine Rather Than a Shallow Gap: Many More Bridges Needed to Improve Care of Chronic Hepatitis B in the United States.
    Am J Gastroenterol. 2021 Jun 30. pii: 00000434-990000000-00023.
    PubMed     Abstract available


  22. YU X
    Pay Attention to Distinguish Hepatitis from Novel Coronavirus Hepatitis in the Context of COVID-19 Pandemic.
    Am J Gastroenterol. 2021;116:1354-1355.
    PubMed    


  23. RINALDI L, Messina V, Di Marco V, Iovinella V, et al
    Factors Enhancing Treatment of Hepatitis C Virus-Infected Italian People Who Use Drugs: The CLEO-GRECAS Experience.
    Am J Gastroenterol. 2021;116:1248-1255.
    PubMed     Abstract available


  24. NGUYEN MH, Atsukawa M, Ishikawa T, Yasuda S, et al
    Outcomes of Sequential Therapy With Tenofovir Alafenamide After Long-term Entecavir.
    Am J Gastroenterol. 2021;116:1264-1273.
    PubMed     Abstract available


    April 2021
  25. TRAN S, Jeong D, Henry L, Cheung RC, et al
    Initial Evaluation, Long-Term Monitoring, and Hepatocellular Carcinoma Surveillance of Chronic Hepatitis B in Routine Practice: A Nationwide US Study.
    Am J Gastroenterol. 2021 Apr 29. pii: 00000434-900000000-98796.
    PubMed     Abstract available


  26. SHARMA S, Saraya A
    Avoiding Beta Blockers in Patients of Hepatitis C Virus-Related Compensated Cirrhosis With Clinically Significant Portal Hypertension After Cure With Antivirals: Are We There Yet?
    Am J Gastroenterol. 2021 Apr 9. pii: 00000434-900000000-98829.
    PubMed    


  27. JI D, Chen Y, Shang Q, Liu H, et al
    Unreliable Estimation of Fibrosis Regression During Treatment by Liver Stiffness Measurement in Patients With Chronic Hepatitis B.
    Am J Gastroenterol. 2021 Apr 8. pii: 00000434-900000000-98824.
    PubMed     Abstract available


  28. KHALILI M, Kleiner DE, King WC, Sterling RK, et al
    Hepatic Steatosis and Steatohepatitis in a Large North American Cohort of Adults With Chronic Hepatitis B.
    Am J Gastroenterol. 2021 Apr 8. pii: 00000434-900000000-98823.
    PubMed     Abstract available


  29. EISA M, Kennedy R, Teferra R, Heckroth M, et al
    SARS-COV-2 Infection in Patients With Alcohol-Associated Hepatitis: Metabolic Similarities and Treatment Challenges.
    Am J Gastroenterol. 2021;116:847-848.
    PubMed    


    March 2021
  30. ROGAL S, Youk A, Agbalajobi O, Zhang H, et al
    Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis.
    Am J Gastroenterol. 2021 Mar 30. pii: 00000434-900000000-98834.
    PubMed     Abstract available


  31. NAM H, Lee SW, Kwon JH, Lee HL, et al
    Prediction of Hepatocellular Carcinoma by On-Therapy Response of Noninvasive Fibrosis Markers in Chronic Hepatitis B.
    Am J Gastroenterol. 2021 Mar 10. pii: 00000434-900000000-98856.
    PubMed     Abstract available


  32. WONG RJ, Jain MK, Therapondos G, Niu B, et al
    Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health Systems.
    Am J Gastroenterol. 2021 Mar 1. pii: 00000434-900000000-98873.
    PubMed     Abstract available


    February 2021
  33. TOSETTI G, Degasperi E, Farina E, D'Ambrosio R, et al
    Decompensation in Direct-Acting Antiviral Cured Hepatitis C Virus Compensated Patients With Clinically Significant Portal Hypertension: Too Rare to Warrant Universal Beta-Blocker Therapy.
    Am J Gastroenterol. 2021 Feb 18. pii: 00000434-900000000-98881.
    PubMed     Abstract available


  34. TAN HK, Teng MLP, Soh AYS, Cheo SHY, et al
    Poor Outcomes of Cirrhosis due to Nonalcoholic Steatohepatitis Compared With Hepatitis B After Decompensation With Ascites.
    Am J Gastroenterol. 2021 Feb 1. doi: 10.14309/ajg.0000000000001176.
    PubMed     Abstract available


    January 2021
  35. WONG GL, Wong VW, Hui VW, Yip TC, et al
    Hepatitis Flare During Immunotherapy in Patients With Current or Past Hepatitis B Virus Infection.
    Am J Gastroenterol. 2021 Jan 28. pii: 00000434-900000000-98894.
    PubMed     Abstract available


  36. XU J, Liang X, Cai X
    A Ring in the Liver.
    Am J Gastroenterol. 2021;116:220-222.
    PubMed    


    December 2020
  37. LI J, Gordon SC, Zhou Y, Boscarino JA, et al
    Sex Differences in Extrahepatic Outcomes After Antiviral Treatment for Hepatitis C.
    Am J Gastroenterol. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  38. DESAI N, Rich NE, Jain MK, Blackwell JM, et al
    Randomized Clinical Trial of Inreach With or Without Mailed Outreach to Promote Hepatitis C Screening in a Difficult-to-Reach Patient Population.
    Am J Gastroenterol. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  39. MCCLAIN CJ, Vatsalya V, Mitchell MC
    Keratin-18: Diagnostic, Prognostic, and Theragnostic for Alcohol-Associated Hepatitis.
    Am J Gastroenterol. 2020 Dec 10. doi: 10.14309/ajg.0000000000001042.
    PubMed     Abstract available


  40. FABIANA B, Cesar A, Marcio C, Carolina M, et al
    P061 Prophylaxis of Hepatitis B Reactivation and Inflammatory Bowel Disease: A case report.
    Am J Gastroenterol. 2020;115.
    PubMed    


    November 2020
  41. ATKINSON SR, Grove JI, Liebig S, Astbury S, et al
    In Severe Alcoholic Hepatitis, Serum Keratin-18 Fragments Are Diagnostic, Prognostic, and Theragnostic Biomarkers.
    Am J Gastroenterol. 2020;115:1857-1868.
    PubMed     Abstract available


  42. CHAPARRO M, Gordillo J, Domenech E, Esteve M, et al
    Fendrix vs Engerix-B for Primo-Vaccination Against Hepatitis B Infection in Patients With Inflammatory Bowel Disease: A Randomized Clinical Trial.
    Am J Gastroenterol. 2020;115:1802-1811.
    PubMed     Abstract available


  43. BANTY A, Melmed GY
    Improving Hepatitis B Virus Vaccination Responses in Inflammatory Bowel Disease: Does Greater Dose and Greater Frequency Lead to Greater Protection?
    Am J Gastroenterol. 2020;115:1797-1798.
    PubMed     Abstract available


  44. SANTOS S, Simoes G, Lemos J, Saiote J, et al
    Long-Term Self-Expandable Metal Stent (SEMS) for Esophageal Variceal Bleeding: A Picture of the Natural History.
    Am J Gastroenterol. 2020;115:1915-1917.
    PubMed     Abstract available


    October 2020
  45. LV XH, Yang JL, Deng K
    COVID-19 Patients With Hepatitis B Virus Infection.
    Am J Gastroenterol. 2020 Oct 26. doi: 10.14309/ajg.0000000000001034.
    PubMed    


  46. EISA M, Kennedy R, Teferra R, Heckroth M, et al
    SARS-COV-2 Infection in Patients With Alcohol-Associated Hepatitis: Metabolic Similarities and Treatment Challenges.
    Am J Gastroenterol. 2020 Oct 19. doi: 10.14309/ajg.0000000000001002.
    PubMed    


  47. SINN DH, Kang D, Guallar E, Chang Y, et al
    Alcohol Intake and Mortality in Patients With Chronic Viral Hepatitis: A Nationwide Cohort Study.
    Am J Gastroenterol. 2020 Oct 8. doi: 10.14309/ajg.0000000000000966.
    PubMed     Abstract available


  48. DA BL, Rahman F, Lai WC, Kleiner DE, et al
    Risk Factors for Delta Hepatitis in a North American Cohort: Who Should Be Screened?
    Am J Gastroenterol. 2020 Oct 7. doi: 10.14309/ajg.0000000000000954.
    PubMed     Abstract available


  49. ATKINSON SR, Grove JI, Liebig S, Astbury S, et al
    In Severe Alcoholic Hepatitis, Serum Keratin-18 Fragments Are Diagnostic, Prognostic, and Theragnostic Biomarkers.
    Am J Gastroenterol. 2020 Oct 1. doi: 10.14309/ajg.0000000000000912.
    PubMed     Abstract available


  50. SHARMA S, Agarwal S, Gunjan D, Kaushal K, et al
    Deciding Among Noninvasive Tools for Predicting Varices Needing Treatment in Chronic Liver Disease: An Analysis of Asian Cohort.
    Am J Gastroenterol. 2020;115:1650-1656.
    PubMed     Abstract available


    September 2020
  51. CHAPARRO M, Gordillo J, Domenech E, Esteve M, et al
    Fendrix vs Engerix-B for Primo-Vaccination Against Hepatitis B Infection in Patients With Inflammatory Bowel Disease: A Randomized Clinical Trial.
    Am J Gastroenterol. 2020 Sep 30. doi: 10.14309/ajg.0000000000000926.
    PubMed     Abstract available


  52. BANTY A, Melmed GY
    Improving Hepatitis B Virus Vaccination Responses in Inflammatory Bowel Disease: Does Greater Dose and Greater Frequency Lead to Greater Protection?
    Am J Gastroenterol. 2020 Sep 25. doi: 10.14309/ajg.0000000000000921.
    PubMed     Abstract available


  53. HE Q, Zhang G, Gu Y, Wang J, et al
    Clinical Characteristics of COVID-19 Patients With Pre-existing Hepatitis B Virus Infection: A Multicenter Report.
    Am J Gastroenterol. 2020 Sep 11. doi: 10.14309/ajg.0000000000000924.
    PubMed    


    August 2020
  54. TEH KK, Soh NY, Lim KW, Ng KY, et al
    Use of Percutaneous Radiofrequency Ablation in Paracentesis-Related Intraperitoneal Hemorrhage From a Bleeding Abdominal Wall Vessel.
    Am J Gastroenterol. 2020;115:1299-1300.
    PubMed    


    July 2020
  55. SAINATH KG, Vasan A, Singh V
    Serum Transferrin Is an Independent Predictor of Mortality in Severe Alcoholic Hepatitis: Upping the Game or Just Upping the Ante?
    Am J Gastroenterol. 2020;115:1136.
    PubMed    


  56. HAO SR, Zhang SY, Lian JS, Jin X, et al
    Liver Enzyme Elevation in Coronavirus Disease 2019: A Multicenter, Retrospective, Cross-Sectional Study.
    Am J Gastroenterol. 2020;115:1075-1083.
    PubMed     Abstract available


  57. THULUVATH PJ, Bruno DA, Alukal J, Satapathy SK, et al
    Use of HCV-Positive Livers in HCV-Negative Recipients.
    Am J Gastroenterol. 2020;115:1045-1054.
    PubMed     Abstract available


  58. POLANCO NP, Goldberg D
    Transplanting Livers From "HCV-Positive" Donors To HCV-Negative Recipients: Increased Experience But Many Unanswered Questions.
    Am J Gastroenterol. 2020;115:1022-1023.
    PubMed     Abstract available


  59. ATKINSON SR, Thursz MR, Strnad P
    Response to Sainath et al.
    Am J Gastroenterol. 2020;115:1136-1137.
    PubMed    


  60. RUBIN JN, Gilman CAL, Gasmi B, Stern WR, et al
    Hepatocellular Carcinoma Where You Least Expect It.
    Am J Gastroenterol. 2020;115:1134-1136.
    PubMed    


    June 2020
  61. LIM JK, Nguyen MH, Kim WR, Gish R, et al
    Prevalence of Chronic Hepatitis B Virus Infection in the United States.
    Am J Gastroenterol. 2020 Jun 1. doi: 10.14309/ajg.0000000000000651.
    PubMed     Abstract available


  62. ATKINSON SR, Thursz MR, Strnad P
    Response to Diao et al.
    Am J Gastroenterol. 2020;115:958.
    PubMed    


    May 2020
  63. SAKAI N, Kamimura K, Terai S
    Multiple Tumor-Like Fatty Changes in the Liver Disappeared After Hepatitis C Virus Eradication With Direct-Acting Antiviral Treatment.
    Am J Gastroenterol. 2020 May 22. doi: 10.14309/ajg.0000000000000703.
    PubMed    


  64. POLANCO NP, Goldberg D
    Transplanting Livers From "HCV-Positive" Donors To HCV-Negative Recipients: Increased Experience But Many Unanswered Questions.
    Am J Gastroenterol. 2020 May 20. doi: 10.14309/ajg.0000000000000649.
    PubMed     Abstract available


  65. YIM HJ, Kim W, Ahn SH, Yang JM, et al
    Besifovir Dipivoxil Maleate 144-Week Treatment of Chronic Hepatitis B: An Open-Label Extensional Study of a Phase 3 Trial.
    Am J Gastroenterol. 2020 May 1. doi: 10.14309/ajg.0000000000000605.
    PubMed     Abstract available


  66. SANDY NS, Hessel G, Bellomo-Brandao MA
    Major Complications of Pediatric Percutaneous Liver Biopsy Do Not Differ Among Physicians With Different Degrees of Training.
    Am J Gastroenterol. 2020;115:786-789.
    PubMed     Abstract available


    April 2020
  67. SAINATH KG, Vasan A, Singh V
    Serum Transferrin Is an Independent Predictor of Mortality in Severe Alcoholic Hepatitis: Upping the Game or Just Upping the Ante?
    Am J Gastroenterol. 2020 Apr 23. doi: 10.14309/ajg.0000000000000657.
    PubMed    


  68. WANDER P, Epstein M, Bernstein D
    COVID-19 Presenting as Acute Hepatitis.
    Am J Gastroenterol. 2020 Apr 15. doi: 10.14309/ajg.0000000000000660.
    PubMed    


  69. DIAO YK, Jia HD, Huang DS, Zhang CW, et al
    Is Serum Transferrin an Independent Predictor of Mortality in Severe Alcoholic Hepatitis?
    Am J Gastroenterol. 2020 Apr 15. doi: 10.14309/ajg.0000000000000601.
    PubMed    


    March 2020
  70. HUANG CF, Lai HC, Chen CY, Tseng KC, et al
    Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH).
    Am J Gastroenterol. 2020 Mar 26. doi: 10.14309/ajg.0000000000000606.
    PubMed     Abstract available


    December 2019
  71. ARSLAN F, Vahaboglu H
    Tenofovir for the Prevention of HCC in Patients With Cirrhosis.
    Am J Gastroenterol. 2019 Dec 16. doi: 10.14309/ajg.0000000000000477.
    PubMed    


    November 2019
  72. KIDAMBI TD, Chu P, Lee JK, Lin JL, et al
    Immunotherapy-Associated Pseudomembranous Colitis.
    Am J Gastroenterol. 2019;114:1708.
    PubMed    


    August 2019
  73. YOUNOSSI ZM, Stepanova M, Lawitz EJ, Reddy KR, et al
    Patients With Nonalcoholic Steatohepatitis Experience Severe Impairment of Health-Related Quality of Life.
    Am J Gastroenterol. 2019 Aug 20. doi: 10.14309/ajg.0000000000000375.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: